### **Patient eligibility and diagnosis** Documentation must confirm that through thorough patient assessment, it is found that they have severe eosinophilic asthma, evidenced by a blood eosinophil count 150 cells/L within six weeks of dosing, and persistent severe asthma uncontrolled despite treatment with high-dosage inhaled corticosteroids plus a second controller
Even then, these findings remain preclinical
This guide walks through the exact documented protocol for a 70 mg GLOW vial: how to reconstitute it, how much each microdose actually delivers per component, how often the research schedule administers it, and how a full on/off cycle is structured
Apply gentle pressure with a clean swab if needed
After this period, the vial should be discarded
The impact of B12 and Folate depletion extends deeply into the central nervous system, driving the cognitive impairment commonly referred to as brain fog